- Assistant Professor, Veterinary Pathobiology, School of Veterinary Medicine and Biomedical Sciences
Dr. Galloway-Pena's studies incorporate the genetic basis of pathogenesis as well as the molecular epidemiology of clinically relevant gram-positive pathogens, focusing on those with multi-drug resistance. She has more recently shifted her focus to microbiome dynamics during cancer treatment and the intense antibiotic therapy seen in the hematological malignancy setting to determine the microbiome's impact on cancer treatment outcomes, toxicities, and colonization/infection by antibiotic resistant organisms. Applications of her research include determining genetic and chemical markers for microbial diversity that can be used in the clinical setting, designing predictive risk models for antibiotic resistant infectious risk during chemotherapy, and promoting antimicrobial stewardship and microbial conscious treatment.
- Ph.D. in Microbiology and Molecular Genetics, The University of Texas Health Science Center at Houston - (Houston, Texas, United States) 2013
- B.A. in Biology, Cum Laude, Our Lady of the Lake University - (San Antonio, Texas, United States) 2006
Academic Articles55
- Singh, K. V., Galloway-Pea, J., Montealegre, M. C., Dong, X., & Murray, B. E. (2024). Genomic context as well as sequence of both psr and penicillin-binding protein 5 contributes to -lactam resistance in Enterococcus faecium.. mBio. e0017024.
- Galloway-Pea, J., Iliev, I. D., & McAllister, F. (2024). Fungi in cancer.. Nature Reviews Cancer. 1-4.
- Kwon, J., Pelletiers, W., Pea, J. G., van Duin, D., Ledbetter, L., Baum, K., ... Pettigrew, M. M. (2024). Participant Diversity in United States Randomized Controlled Trials of Antibacterials for Staphylococcus aureus Infections, 20002021. Clinical Infectious Diseases.
- Ossa-Trujillo, C., Taylor, E. A., Sarwar, F., Vinasco, J., Jordan, E. R., Buitrago, J., ... Scott, H. M. (2023). Two-Dose Ceftiofur Treatment Increases Cephamycinase Gene Quantities and Fecal Microbiome Diversity in Dairy Cows Diagnosed with Metritis. 11(11), 2728-2728.
- Galloway-Pea, J. R., & Jobin, C. (2023). Microbiota Influences on Hematopoiesis and Blood Cancers: New Horizons?. 4(4), 267-275.
Conference Papers1
- Hayase, E., Hayase, T., Jamal, M. A., Miyama, T., Chang, C., Ortega, M. R., ... Jenq, R. R. (2022). Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease. Leading Edge of Cancer Research Symposium: Poster Session.
Repository Documents / Preprints3
- Zhang, Y., Wang, J., Shen, J., Galloway-Pena, J., Shelburne, S., Wang, L., & Hu, J. (2021). Inverse Probability Weighting-based Mediation Analysis for Microbiome Data.
- Schwabkey, Z., Wiesnoski, D. H., Chang, C., Tsai, W., Pham, D., Ahmed, S. S., ... Jenq, R. R. (2021). Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment.
- Shropshire, W. C., Aitken, S. L., Pifer, R., Kim, J., Bhatti, M. M., Li, X., ... Shelburne, S. A. (2019). Concurrence of Porin Loss and Modular Amplification of -Lactamase Encoding Genes Drives Carbapenem Resistance in a Cohort of Recurrent Enterobacterales Bacteremia.
Co-Principal Investigator1
- BIMS491 Hnr-research Instructor
- BIMS491 Research Instructor
- GENE491 Hnr-research Instructor
- GENE491 Research Instructor
- GENE608 Crit Analysis Gene Lit Instructor